J Koshiol

Summary

Affiliation: National Institutes of Health
Country: USA

Publications

  1. ncbi request reprint Time to clearance of human papillomavirus infection by type and human immunodeficiency virus serostatus
    Jill E Koshiol
    Department of Epidemiology, University of North Carolina, Chapel Hill, NC, USA
    Int J Cancer 119:1623-9. 2006
  2. pmc Inflammatory gene variants and the risk of biliary tract cancers and stones: a population-based study in China
    Felipe A Castro
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, 6120 Executive Blvd, Rockville, MD 20892, USA
    BMC Cancer 12:468. 2012
  3. pmc Reproducibility of linear array for human papillomavirus genotyping
    Jill Koshiol
    Division of Cancer Epidemiology and Genetics, NCI NIH DHHS, Bethesda, Maryland, USA
    J Clin Microbiol 51:625-8. 2013
  4. pmc Helicobacter pylori seropositivity and risk of lung cancer
    Jill Koshiol
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, US Department of Health and Human Services, Bethesda, Maryland, United States of America
    PLoS ONE 7:e32106. 2012
  5. pmc Evaluation of normalization methods for two-channel microRNA microarrays
    Yingdong Zhao
    Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA
    J Transl Med 8:69. 2010
  6. pmc The gastric cardia is not a target for human papillomavirus-induced carcinogenesis
    Jill Koshiol
    Infections and Immunoepidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, 6120 Executive Boulevard, Room 7070, Rockville, MD 20852 7248, USA
    Cancer Epidemiol Biomarkers Prev 19:1137-9. 2010
  7. pmc Strengths and limitations of laboratory procedures for microRNA detection
    Jill Koshiol
    Infections and Immunepidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, 6120 Executive Boulevard, Room 7070, Rockville, MD 20852 7248, USA
    Cancer Epidemiol Biomarkers Prev 19:907-11. 2010
  8. pmc Racial differences in chronic immune stimulatory conditions and risk of non-Hodgkin's lymphoma in veterans from the United States
    Jill Koshiol
    National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD 20892 7248, USA
    J Clin Oncol 29:378-85. 2011
  9. pmc Assessment of human papillomavirus in lung tumor tissue
    Jill Koshiol
    Infections and Immunoepidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD 20892 7248, USA
    J Natl Cancer Inst 103:501-7. 2011
  10. pmc Epstein-Barr virus microRNAs and lung cancer
    J Koshiol
    Infections and Immunoepidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD, USA
    Br J Cancer 105:320-6. 2011

Detail Information

Publications23

  1. ncbi request reprint Time to clearance of human papillomavirus infection by type and human immunodeficiency virus serostatus
    Jill E Koshiol
    Department of Epidemiology, University of North Carolina, Chapel Hill, NC, USA
    Int J Cancer 119:1623-9. 2006
    ..57 (95% CI: 0.22-1.45) for HIV-positive and -negative women, respectively. HPV types within the high-risk category had low estimated clearance rates relative to low-risk types, but HRs were not substantially modified by HIV serostatus...
  2. pmc Inflammatory gene variants and the risk of biliary tract cancers and stones: a population-based study in China
    Felipe A Castro
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, 6120 Executive Blvd, Rockville, MD 20892, USA
    BMC Cancer 12:468. 2012
    ..Genetic variants in inflammation-related genes have been associated with biliary stones and biliary tract cancers in previous studies...
  3. pmc Reproducibility of linear array for human papillomavirus genotyping
    Jill Koshiol
    Division of Cancer Epidemiology and Genetics, NCI NIH DHHS, Bethesda, Maryland, USA
    J Clin Microbiol 51:625-8. 2013
    ..3% overall [Kappa = 0.9] and 86.8% for carcinogenic types [Kappa = 0.92]). Discordance was highest with a low hybridization signal strength. Overall, Linear Array was highly reproducible...
  4. pmc Helicobacter pylori seropositivity and risk of lung cancer
    Jill Koshiol
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, US Department of Health and Human Services, Bethesda, Maryland, United States of America
    PLoS ONE 7:e32106. 2012
    ..pylori seropositivity. Despite earlier small studies suggesting that H. pylori may contribute to lung carcinogenesis, H. pylori seropositivity does not appear to be associated with lung cancer...
  5. pmc Evaluation of normalization methods for two-channel microRNA microarrays
    Yingdong Zhao
    Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA
    J Transl Med 8:69. 2010
    ..Findings from previous studies have sometimes been inconclusive or contradictory. Further studies to determine optimal normalization methods for miR microarrays are needed...
  6. pmc The gastric cardia is not a target for human papillomavirus-induced carcinogenesis
    Jill Koshiol
    Infections and Immunoepidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, 6120 Executive Boulevard, Room 7070, Rockville, MD 20852 7248, USA
    Cancer Epidemiol Biomarkers Prev 19:1137-9. 2010
    ..Given the availability of an effective HPV vaccine and its potential to prevent HPV-associated cancer, we decided to evaluate the prevalence of HPV DNA in GCA...
  7. pmc Strengths and limitations of laboratory procedures for microRNA detection
    Jill Koshiol
    Infections and Immunepidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, 6120 Executive Boulevard, Room 7070, Rockville, MD 20852 7248, USA
    Cancer Epidemiol Biomarkers Prev 19:907-11. 2010
    ..MicroRNAs (miR) are endogenous, noncoding RNAs involved in many cellular processes and have been associated with the development and progression of cancer. There are many different ways to evaluate miRs...
  8. pmc Racial differences in chronic immune stimulatory conditions and risk of non-Hodgkin's lymphoma in veterans from the United States
    Jill Koshiol
    National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD 20892 7248, USA
    J Clin Oncol 29:378-85. 2011
    ..To examine underlying etiologic factors that may explain the racial disparity in non-Hodgkin's lymphoma (NHL) incidence patterns...
  9. pmc Assessment of human papillomavirus in lung tumor tissue
    Jill Koshiol
    Infections and Immunoepidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD 20892 7248, USA
    J Natl Cancer Inst 103:501-7. 2011
    ..Lung cancer kills more than 1 million people worldwide each year. Whereas several human papillomavirus (HPV)-associated cancers have been identified, the role of HPV in lung carcinogenesis remains controversial...
  10. pmc Epstein-Barr virus microRNAs and lung cancer
    J Koshiol
    Infections and Immunoepidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD, USA
    Br J Cancer 105:320-6. 2011
    ..We conducted the first analysis of viral microRNAs (miRNAs) in lung cancer, with a focus on Epstein-Barr virus (EBV)...
  11. pmc Lower risk of lung cancer after multiple pneumonia diagnoses
    Jill Koshiol
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, 6120 Executive Boulevard, MSC 7248, Bethesda, MD 20892 7248, USA
    Cancer Epidemiol Biomarkers Prev 19:716-21. 2010
    ..Although pneumonia has been suggested as a risk factor for lung cancer, previous studies have not evaluated the influence of number of pneumonia diagnoses in relation to lung cancer risk...
  12. pmc Chronic immune stimulation and subsequent Waldenström macroglobulinemia
    Jill Koshiol
    Cancer Prevention Fellowship Program, Office of Preventive Oncology, and Division of Genetic Epidemiology Branch, National Cancer Institute, 6120 Executive Blvd, EPS 7003, MSC 7236, Bethesda, MD 20892 7236, USA
    Arch Intern Med 168:1903-9. 2008
    ..A few previous studies suggest that chronic inflammation may particularly elevate risk of the distinct non-Hodgkin lymphoma subtype Waldenström macroglobulinemia (WM)...
  13. pmc Epstein-Barr virus serology and gastric cancer incidence and survival
    J Koshiol
    Cancer Prevention Fellowship, Division of Cancer Prevention, National Cancer Institute, 6120 Executive Blvd, MSC 7236, Bethesda, MD, USA
    Br J Cancer 97:1567-9. 2007
    ..High EBV nuclear antigen titres were associated with longer survival in cardia cancer cases, possibly due to chance...
  14. pmc Persistent human papillomavirus infection and cervical neoplasia: a systematic review and meta-analysis
    Jill Koshiol
    Cancer Prevention Fellowship Program, Division of Cancer Prevention, National Cancer Institute, Bethesda, MD 20892 7236, USA
    Am J Epidemiol 168:123-37. 2008
    ..Precise definition and standardization of HPV testing, sampling procedure, and test interval are needed for reliable clinical testing. These findings validate HPV persistence as a clinical marker and endpoint...
  15. ncbi request reprint Smoking and time to clearance of human papillomavirus infection in HIV-seropositive and HIV-seronegative women
    Jill Koshiol
    Department of Epidemiology, School of Public Health, University of North Carolina at Chapel Hill, USA
    Am J Epidemiol 164:176-83. 2006
    ..93, 95% CI: 0.68, 1.26) women. HPV clearance did not appear to vary by amount or duration of smoking. Smoking did not modify overall clearance but was associated with lower high-risk HPV clearance in HIV-seronegative women...
  16. pmc Common genetic variation in TP53 and risk of human papillomavirus persistence and progression to CIN3/cancer revisited
    Jill Koshiol
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD 20852 7248, USA
    Cancer Epidemiol Biomarkers Prev 18:1631-7. 2009
    ..Although genetic variation in TP53 might affect the natural history of HPV and cervical cancer, further work is needed to elucidate the possible mechanism...
  17. pmc Knowledge of human papillomavirus: differences by self-reported treatment for genital warts and sociodemographic characteristics
    Jill Koshiol
    Cancer Prevention Fellowship Program, Office of Preventive Oncology and Genetic Epidemiology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA
    J Health Commun 14:331-45. 2009
    ..Women with genital warts are learning about HPV, but socioeconomically disadvantaged groups may need to be targeted...
  18. pmc Chronic obstructive pulmonary disease and altered risk of lung cancer in a population-based case-control study
    Jill Koshiol
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland, United States of America
    PLoS ONE 4:e7380. 2009
    ..Chronic obstructive pulmonary disease (COPD) has been consistently associated with increased risk of lung cancer. However, previous studies have had limited ability to determine whether the association is due to smoking...
  19. pmc No role for human papillomavirus in esophageal squamous cell carcinoma in China
    Jill Koshiol
    Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, National Institutes of Health, Bethesda, MD 20852 7248, USA
    Int J Cancer 127:93-100. 2010
    ..HPV DNA contamination cannot be ruled out as an explanation for high HPV prevalence in ESCC tissue studies with less stringent tissue procurement and processing protocols...
  20. pmc Inherited polymorphisms in the RNA-mediated interference machinery affect microRNA expression and lung cancer survival
    M Rotunno
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, 6120 Executive Boulevard, Bethesda, MD 20892 7248, USA
    Br J Cancer 103:1870-4. 2010
    ..Single-nucleotide polymorphisms (SNPs) in genes involved in miR biogenesis may affect miR expression in lung tissue and be associated with lung carcinogenesis and progression...
  21. ncbi request reprint Cancer control-planning and monitoring population-based systems
    Joe B Harford
    Office of International Affairs, National Cancer Institute, EPN100, Bethesda, MD 20892, USA
    Tumori 95:568-78. 2009
    ..Experiences from around the world are reviewed to highlight the issues and showcase some possible solutions...
  22. pmc Aspirin but not ibuprofen use is associated with reduced risk of prostate cancer: a PLCO study
    F M Shebl
    Department of Human Health and Services, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Rockville, MD, USA
    Br J Cancer 107:207-14. 2012
    ..Although most epidemiological studies suggest that non-steroidal anti-inflammatory drug use is inversely associated with prostate cancer risk, the magnitude and specificity of this association remain unclear...
  23. ncbi request reprint Rate and predictors of new genital warts claims and genital warts-related healthcare utilization among privately insured patients in the United States
    Jill E Koshiol
    Department of Epidemiology, The University of North Carolina, Chapel Hill, North Carolina 27709 3398, USA
    Sex Transm Dis 31:748-52. 2004
    ..Little non-clinic-based data are available on incident genital warts rates and related healthcare use...